PLRX (pliantrx.com) Earnings per share growth this year

Official company branding of Pliant Therapeutics (PLRX)

Pliant Therapeutics (PLRX) focuses on hypothetical revenues from the fight against fibrosis. The year-over-year change in EPS visualizes this trajectory, where the 41.50 metric indicates the efficiency status. Success is based on the patent protection of small molecules and strict FDA control, despite an aggressive race with global pharma behemoths for leadership in lung treatment.

PLRX (Pliant Therapeutics, Inc.) Earnings per share growth in current year history from 07/04/2022 to 11/15/2026

Financial and market metric breakdowns for Pliant Therapeutics, Inc. (PLRX)

Basic company analysis:pliantrx.com (PLRX)
Manufactured products of pliantrx.com

This indicator reflects the dynamics of earnings per share, measuring the efficiency of converting operating activities into shareholder returns. For Pliant Therapeutics (PLRX), the year-over-year growth in earnings per share signals market confidence in the development of integrin inhibitors. The positive trend confirms a reduction in pipeline risks following approvals from US regulators. It is critical for investors to evaluate this pace as an indicator of the capitalization of future successes. A sharp slowdown in growth could indicate a stagnation of clinical expectations.

Main competitors

Earnings per share growth rate in current year Vertex Pharmaceuticals Inc. (VRTX)|ALNY (Alnylam) - Earnings growth in current year|Earnings per share growth this year INSM (Insmed)|Net earnings per share growth this year UTHR (United Therapeutics Corporation)|BMRN (BioMarin Pharmaceutical Inc.) - Earnings per share increase in current year|Earnings per share growth in current year BridgeBio BBIO|Earnings per share increase in current year BGM|Cogent Biosciences - Earnings growth in current year|Earnings per share increase in current year XERS (Xeris Biopharma)|KROS: Earnings growth in current year|Arcturus Therapeutics Inc (ARCT) - Earnings growth in current year|Earnings per share growth in current year Eton Pharma|KMDA: Earnings per share increase in current year|Earnings per share growth in current year fulcrumtx.com (FULC)|Net earnings per share growth this year Abeona Therapeutics Inc. ABEO|Earnings growth in current year MREO (Mereo BioPharma Group)|PLX (Protalix BioTherapeutics Inc.) - Earnings per share trend in current year|appliedtherapeutics.com - Earnings growth in current year|Earnings per share increase in current year RNTX (Rein Therapeutics, Inc.)|GELS: Earnings growth in current year|Earnings per share growth rate in current year Aytu BioPharma, Inc. (AYTU)|CMMB (Chemomab Therapeutics Ltd) - Earnings growth in current year|Earnings per share growth this year SRXH (SRx Health Solutions)|Net earnings per share growth this year PLRZ (Polyrizon Ltd)|AEZS - Earnings per share growth rate in current year|Earnings per share growth in current year Cyclo Therapeutics Inc. CYTH|Inozyme Pharma, Inc. (INZY) - Earnings per share growth rate in current year|RPHM: Net earnings per share growth this year|Earnings per share growth rate in current year COSCIENS Biopharma Inc